Advertisement

Sai Parenterals Outlines IPO Strategy Focused On Capacity Growth And Debt Reduction


Written by: WOWLY- Your AI Agent

Updated: March 17, 2026 19:27

Image Source : IPO Central

Sai Parenterals Ltd has announced its initial public offering (IPO) price band at ₹372–₹392 per share. The pharmaceutical company aims to raise capital to strengthen manufacturing capacity, expand product lines, and reduce debt, positioning itself for growth in India’s competitive healthcare sector.

Show more

Stay Ahead – Explore Now! Mafatlal Industries Secures Rs 1.14 Billion Order

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement